US Stock MarketDetailed Quotes

DiaMedica Therapeutics (DMAC)

Watchlist
  • 6.520
  • +0.270+4.32%
Close May 6 16:00 ET
  • 6.520
  • 0.0000.00%
Post 20:01 ET
351.31MMarket Cap-9.31P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

DiaMedica Therapeutics (DMAC) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-31.65%-29.06M
-20.69%-7.77M
-46.53%-6.55M
-68.13%-7.6M
-7.46%-7.15M
-17.88%-22.08M
-68.78%-6.43M
6.82%-4.47M
10.16%-4.52M
-30.73%-6.65M
Net income from continuing operations
-34.05%-32.77M
-10.63%-8.74M
-37.39%-8.62M
-50.40%-7.7M
-49.62%-7.71M
-26.12%-24.44M
-53.07%-7.9M
-40.33%-6.27M
-14.34%-5.12M
2.30%-5.15M
Depreciation and amortization
10.26%43K
0.00%11K
80.00%18K
-70.00%3K
37.50%11K
30.00%39K
37.50%11K
25.00%10K
42.86%10K
14.29%8K
Other non cash items
9.33%82K
10.53%21K
10.53%21K
5.26%20K
11.11%20K
7.14%75K
5.56%19K
5.56%19K
11.76%19K
5.88%18K
Change In working capital
-55.36%675K
-99.75%3K
-19.75%1.26M
-214.77%-513K
95.32%-79K
1,525.81%1.51M
-4.62%1.18M
546.18%1.58M
161.23%447K
-2,808.62%-1.69M
-Change in receivables
-116.54%-22K
-96.30%2K
-198.02%-99K
1,050.00%92K
43.33%-17K
146.34%133K
191.53%54K
182.79%101K
106.11%8K
-220.00%-30K
-Change in prepaid assets
193.77%1.05M
209.43%164K
-18.12%235K
-1,650.00%-31K
146.79%686K
-602.50%-1.12M
-92.43%53K
165.83%287K
-99.30%2K
-106.19%-1.47M
-Change in payables and accrued expense
-114.26%-357K
-115.23%-163K
-4.97%1.13M
-231.35%-574K
-291.62%-748K
363.52%2.5M
80.44%1.07M
479.02%1.19M
149.32%437K
-130.41%-191K
Cash from discontinued investing activities
Operating cash flow
-31.65%-29.06M
-20.69%-7.77M
-46.53%-6.55M
-68.13%-7.6M
-7.46%-7.15M
-17.88%-22.08M
-68.78%-6.43M
6.82%-4.47M
10.16%-4.52M
-30.73%-6.65M
Investing cash flow
Cash flow from continuing investing activities
-125.60%-2.19M
53.60%8M
-361.34%-25.77M
89.13%8.96M
57.37%6.62M
146.80%8.56M
-15.01%5.21M
-566.97%-5.59M
116.84%4.74M
67.72%4.21M
Net PPE purchase and sale
-60.00%-40K
14.29%-6K
-77.78%-16K
---6K
-33.33%-12K
-4.17%-25K
-133.33%-7K
10.00%-9K
--0
-28.57%-9K
Net investment purchase and sale
-125.06%-2.15M
53.51%8M
-361.80%-25.75M
89.25%8.96M
57.32%6.63M
147.00%8.59M
-14.93%5.21M
-562.35%-5.58M
116.84%4.74M
67.61%4.22M
Cash from discontinued investing activities
Investing cash flow
-125.60%-2.19M
53.60%8M
-361.34%-25.77M
89.13%8.96M
57.37%6.62M
146.80%8.56M
-15.01%5.21M
-566.97%-5.59M
116.84%4.74M
67.72%4.21M
Financing cash flow
Cash flow from continuing financing activities
265.82%43.88M
9,975.83%12.09M
25,536.59%31.53M
-98.63%161K
9,200.00%91K
-67.44%11.99M
12,100.00%120K
2,150.00%123K
-68.11%11.75M
0.00%-1K
Net issuance payments of debt
-11.11%-10K
33.33%-2K
0.00%-3K
0.00%-2K
-200.00%-3K
-50.00%-9K
-200.00%-3K
-50.00%-3K
0.00%-2K
0.00%-1K
Net common stock issuance
268.45%43.28M
--11.76M
--31.53M
----
----
-68.12%11.75M
--0
--0
----
----
Proceeds from stock option exercised by employees
292.19%1M
129.27%282K
269.05%465K
2,228.57%163K
--94K
--256K
--123K
--126K
--7K
--0
Net other financing activities
---400K
--56K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
265.82%43.88M
9,975.83%12.09M
25,536.59%31.53M
-98.63%161K
9,200.00%91K
-67.44%11.99M
12,100.00%120K
2,150.00%123K
-68.11%11.75M
0.00%-1K
Net cash flow
Beginning cash position
-33.41%3.03M
-19.55%3.33M
-70.79%4.11M
23.46%2.59M
-33.41%3.03M
-3.91%4.54M
85.22%4.13M
140.90%14.07M
-2.33%2.1M
-3.91%4.54M
Current changes in cash
931.49%12.62M
1,211.00%12.32M
92.12%-783K
-87.30%1.52M
82.17%-436K
-720.54%-1.52M
-147.99%-1.11M
-175.35%-9.93M
224.19%11.97M
5.23%-2.45M
End cash Position
417.26%15.65M
417.26%15.65M
-19.55%3.33M
-70.79%4.11M
23.46%2.59M
-33.41%3.03M
-33.41%3.03M
85.22%4.13M
140.90%14.07M
-2.33%2.1M
Free cash flow
-31.68%-29.1M
-20.65%-7.77M
-46.60%-6.57M
-68.27%-7.6M
-7.49%-7.16M
-17.86%-22.1M
-68.83%-6.44M
6.82%-4.48M
10.23%-4.52M
-30.73%-6.66M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -31.65%-29.06M-20.69%-7.77M-46.53%-6.55M-68.13%-7.6M-7.46%-7.15M-17.88%-22.08M-68.78%-6.43M6.82%-4.47M10.16%-4.52M-30.73%-6.65M
Net income from continuing operations -34.05%-32.77M-10.63%-8.74M-37.39%-8.62M-50.40%-7.7M-49.62%-7.71M-26.12%-24.44M-53.07%-7.9M-40.33%-6.27M-14.34%-5.12M2.30%-5.15M
Depreciation and amortization 10.26%43K0.00%11K80.00%18K-70.00%3K37.50%11K30.00%39K37.50%11K25.00%10K42.86%10K14.29%8K
Other non cash items 9.33%82K10.53%21K10.53%21K5.26%20K11.11%20K7.14%75K5.56%19K5.56%19K11.76%19K5.88%18K
Change In working capital -55.36%675K-99.75%3K-19.75%1.26M-214.77%-513K95.32%-79K1,525.81%1.51M-4.62%1.18M546.18%1.58M161.23%447K-2,808.62%-1.69M
-Change in receivables -116.54%-22K-96.30%2K-198.02%-99K1,050.00%92K43.33%-17K146.34%133K191.53%54K182.79%101K106.11%8K-220.00%-30K
-Change in prepaid assets 193.77%1.05M209.43%164K-18.12%235K-1,650.00%-31K146.79%686K-602.50%-1.12M-92.43%53K165.83%287K-99.30%2K-106.19%-1.47M
-Change in payables and accrued expense -114.26%-357K-115.23%-163K-4.97%1.13M-231.35%-574K-291.62%-748K363.52%2.5M80.44%1.07M479.02%1.19M149.32%437K-130.41%-191K
Cash from discontinued investing activities
Operating cash flow -31.65%-29.06M-20.69%-7.77M-46.53%-6.55M-68.13%-7.6M-7.46%-7.15M-17.88%-22.08M-68.78%-6.43M6.82%-4.47M10.16%-4.52M-30.73%-6.65M
Investing cash flow
Cash flow from continuing investing activities -125.60%-2.19M53.60%8M-361.34%-25.77M89.13%8.96M57.37%6.62M146.80%8.56M-15.01%5.21M-566.97%-5.59M116.84%4.74M67.72%4.21M
Net PPE purchase and sale -60.00%-40K14.29%-6K-77.78%-16K---6K-33.33%-12K-4.17%-25K-133.33%-7K10.00%-9K--0-28.57%-9K
Net investment purchase and sale -125.06%-2.15M53.51%8M-361.80%-25.75M89.25%8.96M57.32%6.63M147.00%8.59M-14.93%5.21M-562.35%-5.58M116.84%4.74M67.61%4.22M
Cash from discontinued investing activities
Investing cash flow -125.60%-2.19M53.60%8M-361.34%-25.77M89.13%8.96M57.37%6.62M146.80%8.56M-15.01%5.21M-566.97%-5.59M116.84%4.74M67.72%4.21M
Financing cash flow
Cash flow from continuing financing activities 265.82%43.88M9,975.83%12.09M25,536.59%31.53M-98.63%161K9,200.00%91K-67.44%11.99M12,100.00%120K2,150.00%123K-68.11%11.75M0.00%-1K
Net issuance payments of debt -11.11%-10K33.33%-2K0.00%-3K0.00%-2K-200.00%-3K-50.00%-9K-200.00%-3K-50.00%-3K0.00%-2K0.00%-1K
Net common stock issuance 268.45%43.28M--11.76M--31.53M---------68.12%11.75M--0--0--------
Proceeds from stock option exercised by employees 292.19%1M129.27%282K269.05%465K2,228.57%163K--94K--256K--123K--126K--7K--0
Net other financing activities ---400K--56K--------------------------------
Cash from discontinued financing activities
Financing cash flow 265.82%43.88M9,975.83%12.09M25,536.59%31.53M-98.63%161K9,200.00%91K-67.44%11.99M12,100.00%120K2,150.00%123K-68.11%11.75M0.00%-1K
Net cash flow
Beginning cash position -33.41%3.03M-19.55%3.33M-70.79%4.11M23.46%2.59M-33.41%3.03M-3.91%4.54M85.22%4.13M140.90%14.07M-2.33%2.1M-3.91%4.54M
Current changes in cash 931.49%12.62M1,211.00%12.32M92.12%-783K-87.30%1.52M82.17%-436K-720.54%-1.52M-147.99%-1.11M-175.35%-9.93M224.19%11.97M5.23%-2.45M
End cash Position 417.26%15.65M417.26%15.65M-19.55%3.33M-70.79%4.11M23.46%2.59M-33.41%3.03M-33.41%3.03M85.22%4.13M140.90%14.07M-2.33%2.1M
Free cash flow -31.68%-29.1M-20.65%-7.77M-46.60%-6.57M-68.27%-7.6M-7.49%-7.16M-17.86%-22.1M-68.83%-6.44M6.82%-4.48M10.23%-4.52M-30.73%-6.66M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.63%
Sample Name
Sample Code
 +11.47%
Sample Name
Sample Code
 +8.64%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.15%
5
United States Oil Fund LP
USO
+7.52%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +27.18%
Sample Name
Sample Code
 +19.45%
Sample Name
Sample Code
 +17.44%
4
Baidu
BIDU
+16.18%
5
Kingsoft Cloud
KC
+11.69%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -